ARCHIVES

FDA Rejects Genentech Bid For Accelerated Approval For T-DM1. NCI Breaks Ground For Satellite Campus At Shady Grove

This article is from The Cancer Letter archive.

Vol. 36 No. 31 | September 3, 2010

Download PDF Visit The Full Archive

Related Articles

CMS Looks At Coverage of Two Agents Approved on Surrogate Endpoints

March 21, 2003

HRT Doesn’t Raise Cancer Risk Following Oophorectomy

October 28, 2005

ODAC To Review Taxol Nov. 16; NCI, Bristol to Discuss Pricing

October 23, 1992

Letters: NCI Mammography Statement Recognizes Patient Autonomy

February 25, 1994

ONF Offer Grants

February 9, 1996

Nobel Laureate Baruch Blumberg Dies at 85

April 8, 2011